Loading...
XHKG1498
Market cap29mUSD
Dec 27, Last price  
0.58HKD
1D
1.75%
1Q
-14.71%
Jan 2017
-84.49%
IPO
-87.72%
Name

PuraPharm Corp Ltd

Chart & Performance

D1W1MN
XHKG:1498 chart
P/E
—
P/S
0.56
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
9.89%
Rev. gr., 5y
-11.41%
Revenues
407m
-9.20%
342,303,000366,352,000473,900,000535,986,000591,566,000745,503,000695,879,000601,815,000659,592,000448,069,000406,859,000
Net income
-106m
L-11.76%
26,264,00034,463,00028,458,00032,162,0001,889,00020,806,000-227,258,00031,710,000-121,877,000-120,214,000-106,081,000
CFO
80m
+20.90%
11,034,00031,091,000-12,570,000-55,828,000-42,752,00072,461,000101,935,00086,682,000-39,327,00065,848,00079,608,000
Dividend
May 31, 20170.0202 HKD/sh
Earnings
May 23, 2025

Profile

PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers over the counter health products under the PuraGold, Haveron, Oncozac, and Immuzac names. It also provides Chinese medicine clinic management system for general clinic management; and operates Chinese medicine clinics under the Nong's name that provide Chinese medicine services and concentrated Chinese medicine granules products. In addition, the company engages in the plantation and trading of raw Chinese herbs; and manufacture and sale of traditional Chinese medicine decoction pieces. Further, it provides modernized Chinese medicine services; and Chinese medical diagnostic services. The company sells its products to hospitals, healthcare institutions, and medicine practitioners, as well as operates an online store. It operates 43 Nong's clinics in Hong Kong and 1 Nong's clinic in Guangxi, China. The company was founded in 1998 and is headquartered in Tai Po, Hong Kong.
URL
https://www.purapharm.com/
IPO date
Jul 08, 2015
Employees
650
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
406,859
-9.20%
448,069
-32.07%
659,592
9.60%
Cost of revenue
453,408
522,787
649,840
Unusual Expense (Income)
NOPBT
(46,549)
(74,718)
9,752
NOPBT Margin
1.48%
Operating Taxes
3,769
1,032
4,685
Tax Rate
48.04%
NOPAT
(50,318)
(75,750)
5,067
Net income
(106,081)
-11.76%
(120,214)
-1.36%
(121,877)
-484.35%
Dividends
Dividend yield
Proceeds from repurchase of equity
803
BB yield
-0.16%
Debt
Debt current
321,995
428,645
420,910
Long-term debt
142,429
74,512
111,049
Deferred revenue
1,076
1,025
1,174
Other long-term liabilities
14,044
39,055
42,035
Net debt
418,299
371,769
421,783
Cash flow
Cash from operating activities
79,608
65,848
(39,327)
CAPEX
(19,183)
(23,558)
(6,559)
Cash from investing activities
(18,203)
(25,445)
(3,668)
Cash from financing activities
(122,390)
(12,937)
8,772
FCF
66,902
124,414
(13,894)
Balance
Cash
47,221
107,014
85,054
Long term investments
(1,096)
24,374
25,122
Excess cash
25,782
108,985
77,196
Stockholders' equity
(68,335)
39,577
183,590
Invested Capital
661,461
735,703
878,074
ROIC
0.55%
ROCE
1.02%
EV
Common stock shares outstanding
395,053
394,585
393,733
Price
0.90
-29.69%
1.28
58.02%
0.81
19.12%
Market cap
355,548
-29.60%
505,069
58.37%
318,923
26.28%
EV
773,847
876,838
740,706
EBITDA
2,042
(26,057)
59,891
EV/EBITDA
378.97
12.37
Interest
27,407
24,183
27,027
Interest/NOPBT
277.14%